ABIO ARCA biopharma Inc.

0.46
-0.02  -4%
Previous Close 0.48
Open 0.47
Price To Book 0.85
Market Cap 6371649
Shares 13,924,058
Volume 3,440,386
Short Ratio
Av. Daily Volume 804,022

NewsSee all news

  1. ARCA Biopharma Announces FDA Agreement for a Single Phase 3 Clinical Trial to Support Approval for the First Genetically-Targeted Cardiovascular Drug
  2. Zosano Appoints Linda Grais M.D., J.D. to Board of Directors
  3. ARCA biopharma, Inc. (NASDAQ:ABIO) Insiders Have Been Selling
  4. ARCA biopharma Updates Special Protocol Assessment Request to FDA for Gencaro Phase 3 Atrial Fibrillation Clinical Trial
  5. Westminster biotech company receives second extension on delisting notice from Nasdaq

SEC filingsSee all SEC filings

  1. 8-K - Current report 19617093
  2. SC 13G - Statement of acquisition of beneficial ownership by individuals 19589767
  3. SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 19587847
  4. 424B5 - Prospectus [Rule 424(b)(5)] 19543033
  5. 8-K - Current report 19542713

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 trial to be initiated 4Q 2019 under SPA subject to securing additional financing.
Gencaro
Chronic Heart Failure

Latest News

  1. ARCA Biopharma Announces FDA Agreement for a Single Phase 3 Clinical Trial to Support Approval for the First Genetically-Targeted Cardiovascular Drug
  2. Zosano Appoints Linda Grais M.D., J.D. to Board of Directors
  3. ARCA biopharma, Inc. (NASDAQ:ABIO) Insiders Have Been Selling
  4. ARCA biopharma Updates Special Protocol Assessment Request to FDA for Gencaro Phase 3 Atrial Fibrillation Clinical Trial
  5. Westminster biotech company receives second extension on delisting notice from Nasdaq
  6. Today's Research Reports on Trending Tickers: ARCA biopharma and Nektar Therapeutics
  7. Marijuana Stocks: Biotech Stock Report: 3 Companies To Watch In August 2018
  8. 3 Biotech Stocks in Focus on Tuesday
  9. Today’s Research Reports on Stocks to Watch: Progenics Pharmaceuticals and Arca Biopharma
  10. Breakfast Technical Briefing on Alkermes and Three Other Additional Biotech Stocks
  11. Today’s Research Reports on Stocks to Watch: vTv Therapeutics and ARCA Biopharma
  12. Free Technical Insights on Aimmune Therapeutics and Three More Biotech Stocks

SEC Filings

  1. 8-K - Current report 19617093
  2. SC 13G - Statement of acquisition of beneficial ownership by individuals 19589767
  3. SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 19587847
  4. 424B5 - Prospectus [Rule 424(b)(5)] 19543033
  5. 8-K - Current report 19542713
  6. 8-K - Current report 181246529
  7. 8-K - Current report 181184607
  8. 10-Q - Quarterly report [Sections 13 or 15(d)] 181183697
  9. 8-K - Current report 181128484
  10. 8-K - Current report 181113827